This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit June 11, 2015
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  








Check out JMCM’s new website at www.jmcmpub.org

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26. Click here for more information .

 

Fall Managed Care Forum: Register today!
NAMCP

Register today for the 2015 Fall Forum being held November 12-13, 2015 at The Bellagio in Las Vegas. Click here to visit the conference website.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENOMICS


Do creativity and schizophrenia share a small genetic link? Maybe
NPR
The genetic underpinnings of psychosis are elusive and diffuse. There are hundreds of common genetic mutations scattered throughout the human genome that each bump up by just a tiny bit the risk of developing a mental illness like schizophrenia. Many people carry some set of those genes, but most don't end up with a psychotic disorder. Instead, a study suggests, they might be getting a small creative boost.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Explaining 'epigenetics': The health buzzword you need to know
TIME
Most of us get an introduction — whether we remember it or not — to genetics in our first biology class. We learn that genes, made up of DNA, are the molecular blueprint that make us who we are, and that this DNA code is a unique combination of instructions from both our mothers and fathers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Genes do influence when you have your firstborn
Inquisitr
Women may be ignoring their biological clocks and delaying childbirth, but genes may still have some say in the matter, indicate a couple of studies that concluded recently. There’s an interesting contradiction being observed in the modern society. It appears human females are actually evolving to become fertile younger and younger. In other words, girls are now biologically ready to bear children at a much younger age. Needless to say, this makes them more susceptible to teenage pregnancy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


In the future, treatments tailored to patients
The Boston Globe
Holly Boehle came to the Mayo Clinic in 2013 with an aggressive breast cancer, prepared for almost anything. Still, she was surprised when doctors wanted to remove cells from her tumor and transplant them into “avatar mice.” Researchers then injected different cancer drugs into the mice to test which shrank the tumors, findings that will help future patients with the same cancer type.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


How an integrated data approach will impact personalized medicine
Genetic Engineering & Biotechnology News
Genomics have been heralded as ushering in the era of personalized medicine and enabling the development of more targeted and precise therapies. As the industry continues to work toward a stronger approach to personalized medicine — in other words, really being able to stratify patients and match treatments to the right patients at the right time — the use of tissue data in conjunction with genetic data is becoming ever more important.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cell transplant restores sensory functions in injured spinal cord
News-Medical.net
New research from Uppsala University shows promising progress in the use of stem cells for treatment of spinal cord injury. The results, which are published in the scientific journal Scientific Reports, show that human stem cells that are transplanted to the injured spinal cord contribute to restoration of some sensory functions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Recovery of sensory function by stem cell transplants
Medical Xpress
New research from Uppsala University shows promising progress in the use of stem cells for treatment of spinal cord injury. The results, which are published in the scientific journal Scientific Reports, show that human stem cells that are transplanted to the injured spinal cord contribute to restoration of some sensory functions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Mobile health market, digital healthcare technology expands
mHealthIntelligence
The mobile health market is not slowing down anytime soon. Major revolutionary technological advancements are causing the mobile health market to expand. Whether it’s smartwatches, remote monitoring tools, smartphones and tablets, or wearable devices, the sheer volume of technologies as well as applications within the industry shows that it’s expected to continue growing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
SOAPware. Exceptional Software. Empowering Healthcare.
Ranked #1 in the Nation for Quality of Care. Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals! MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


3-D holographic imaging takes medical students inside the human body
Fox News
Deep in the heart of New York’s Hudson Valley is a small medical school doing big things. In July 2014, Touro College of Osteopathic Medicine’s Middletown campus welcomed its very first class of 135 students after a $25 million renovation of an old community hospital. State-of-the-art-technology like robotic simulators and a digital anatomy lab allow students to get an inside look at the human body with 3-D holographic imaging.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


CMS' final ACO rule alters some proposed health IT provisions
iHealthBeat
CMS issued a final rule for its Medicare Shared Savings Program that includes some changes to health IT provisions outlined in a proposed rule, Health Data Management reports. The health IT provisions are part of changes to MSSP that are designed to lower the initial risk of creating an accountable care organization and increase participation in the program.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Bundled payments may be more cost effective than ACOs
FierceHealthFinance
A new report on the Medicare program's attempt to remake the nation's healthcare finance system praised accountable care organizations but also pushed for the continued use of bundled payments to facilitate lower-cost, higher-quality care. In the report, the Center for American Progress asked the Centers for Medicare & Medicaid Services to continue to expand the Medicare Acute Care Episode demonstration program and participate more in the Bundled Payments for Care Improvement initiative.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA: Amgen's Repatha effective; question is for which patients
Reuters
Amgen Inc.'s experimental drug Repatha lowered cholesterol in clinical trials and did not cause a marked disparity in deaths or serious adverse events but showed potential safety issues that should be explored, according to a preliminary review by the U.S. Food and Drug Administration.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA approves mid-stage trial of vaccine to reverse Type 1 diabetes
Reuters via Fox News
Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse Type 1 diabetes. The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin, in 150 adults with advanced cases of the disease. The approval was announced at the 75th Scientific Sessions of the American Diabetes Association by Dr. Denise Faustman, director of the Massachusetts General Hospital Immunobiology Laboratory in Boston and principal investigator of the study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MANAGED HEALTHCARE NEWS


Major inflection point looms for US healthcare costs
CNBC
What do two divergent inflation readings have to do with a blockbuster healthcare deal? Quite a lot, actually. For starters, there is the potential $32 billion-plus deal for health insurance giant Humana, the bulk of whose earnings come from Medicare, the federal program that insures America's elderly. Then, there is the gap between the two leading U.S. core inflation readings, which recently hit a six-year high.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Obama confident supreme court will uphold health insurance subsidies
The Wall Street Journal
President Barack Obama expressed confidence that the Supreme Court would uphold subsidies millions of consumers use to buy health insurance, and at the same time warned of possible dire consequences if that doesn’t happen. Speaking at a news conference in Krun, Germany, at the Group of Seven summit, Obama said, the case, which the Supreme Court is expected to decide near the end of the month “should be an easy case. Frankly, it probably shouldn’t even have been taken up.”
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Quick to laugh or smile? It may be in your genes (Medical Xpress)
Obamacare's 'accountable care' experiment is all hype, no substance (Forbes)
Sex chromosomes: Why the Y genes matter (Science 2.0)
17 percent of our genetic knowledge is wrong (Forbes)
Medicine shows growing potential to repair and regenerate body parts (The Wall Street Journal)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 4, 2015
May 28, 2015
May 21, 2015
May 14, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063